New rabies vaccine shows promise in large trial
NCT ID NCT07357545
First seen Jan 31, 2026 · Last updated Apr 30, 2026 · Updated 10 times
Summary
This study tested a new rabies vaccine in over 2,000 healthy volunteers aged 10-60. Researchers compared different vaccination schedules to see which one triggers the best immune response with the fewest side effects. The goal is to find a safe and effective way to prevent rabies after exposure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RABIES (HEALTHY VOLUNTEERS) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Dazhu County Center for Disease Control and Prevention
Dazhou, China
-
Yuechi County Center for Disease Control and Prevention
Guang’an, China
Conditions
Explore the condition pages connected to this study.